603456 logo

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Stock Price

SHSE:603456 Community·CN¥12.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603456 Share Price Performance

CN¥13.79
-0.13 (-0.93%)
CN¥13.79
-0.13 (-0.93%)
Price CN¥13.79

603456 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Very undervalued with flawless balance sheet and pays a dividend.

2 Risks
5 Rewards

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Key Details

CN¥5.2b

Revenue

CN¥3.3b

Cost of Revenue

CN¥1.9b

Gross Profit

CN¥1.3b

Other Expenses

CN¥652.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
May 07, 2026
0.74
36.58%
12.49%
1.1%
View Full Analysis

About 603456

Founded
1973
Employees
5001
CEO
Yi Jiang Mei
WebsiteView website
www.jiuzhoupharma.com

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

Recent 603456 News & Updates

Recent updates

No updates